LCTX · Lineage Cell Therapeutics, Inc.
$1.07
+0.01 (+0.94%)
At close · Aug 14
View the 10-K filed Mar 5, 2026
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$270.61M
Shares
252.91M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 960,659 | 1,191,200 | 2,151,859 | 44.8% |
| 2026-06-29 | 789,001 | 1,180,388 | 1,969,389 | 51.4% |
| 2026-06-22 | 1,448,706 | 5,012,910 | 6,461,616 | 24.2% |
| 2026-06-15 | 720,739 | 1,508,323 | 2,229,062 | 36.8% |
| 2026-06-08 | 873,071 | 1,965,970 | 2,839,041 | 49.5% |
| 2026-06-01 | 895,128 | 1,836,500 | 2,731,628 | 53.0% |
| 2026-05-25 | 835,269 | 888,827 | 1,724,096 | 49.6% |
| 2026-05-18 | 1,047,226 | 1,607,232 | 2,654,458 | 44.8% |
| 2026-05-11 | 1,025,460 | 3,249,791 | 4,275,251 | 52.0% |
| 2026-05-04 | 1,311,132 | 2,874,181 | 4,185,313 | 56.4% |
| 2026-04-27 | 1,045,438 | 2,692,544 | 3,737,982 | 50.3% |
| 2026-04-20 | 615,309 | 1,195,438 | 1,810,747 | 45.0% |
| 2026-04-13 | 1,149,668 | 1,672,760 | 2,822,428 | 44.4% |
| 2026-04-06 | 1,041,286 | 1,243,533 | 2,284,819 | 42.6% |
| 2026-03-30 | 482,382 | 994,063 | 1,476,445 | 44.7% |
| 2026-03-23 | 841,855 | 1,885,625 | 2,727,480 | 45.2% |
| 2026-03-16 | 727,830 | 1,860,689 | 2,588,519 | 45.2% |
| 2026-03-09 | 1,014,918 | 2,865,400 | 3,880,318 | 53.0% |
| 2026-03-02 | 1,062,811 | 2,289,850 | 3,352,661 | 51.4% |
| 2026-02-23 | 843,742 | 1,760,059 | 2,603,801 | 50.2% |
| 2026-02-16 | 736,839 | 1,034,074 | 1,770,913 | 50.9% |
| 2026-02-09 | 1,422,834 | 2,169,976 | 3,592,810 | 51.0% |
| 2026-02-02 | 1,182,340 | 2,198,141 | 3,380,481 | 48.5% |
| 2026-01-26 | 840,116 | 2,556,205 | 3,396,321 | 56.3% |
| 2026-01-19 | 439,702 | 770,634 | 1,210,336 | 46.1% |
| 2026-01-12 | 1,089,071 | 1,511,391 | 2,600,462 | 48.8% |
| 2026-01-05 | 1,005,777 | 2,025,154 | 3,030,931 | 51.3% |
| 2025-12-29 | 597,775 | 1,667,292 | 2,265,067 | 58.4% |
| 2025-12-22 | 1,084,276 | 1,158,070 | 2,242,346 | 53.8% |
| 2025-12-15 | 1,269,304 | 2,498,718 | 3,768,022 | 41.5% |
| 2025-12-08 | 773,495 | 1,712,901 | 2,486,396 | 56.8% |
| 2025-12-01 | 1,573,328 | 2,557,344 | 4,130,672 | 53.6% |
| 2025-11-24 | 1,115,550 | 2,093,628 | 3,209,178 | 50.6% |
| 2025-11-17 | 969,330 | 2,416,506 | 3,385,836 | 51.4% |
| 2025-11-10 | 1,205,512 | 15,317,182 | 16,522,694 | 78.4% |
| 2025-11-03 | 1,793,837 | 4,866,202 | 6,660,039 | 55.3% |
| 2025-10-27 | 1,358,911 | 4,308,125 | 5,667,036 | 57.2% |
| 2025-10-20 | 1,423,930 | 2,881,606 | 4,305,536 | 50.2% |
| 2025-10-13 | 2,660,375 | 2,670,100 | 5,330,475 | 62.9% |
| 2025-10-06 | 2,403,645 | 3,090,174 | 5,493,819 | 54.9% |
| 2025-09-29 | 1,460,652 | 3,952,818 | 5,413,470 | 57.9% |
| 2025-09-22 | 997,486 | 4,115,352 | 5,112,838 | 63.5% |
| 2025-09-15 | 1,069,981 | 4,515,291 | 5,585,272 | 56.9% |
| 2025-09-08 | 952,705 | 3,773,290 | 4,725,995 | 64.6% |
| 2025-09-01 | 463,633 | 2,008,933 | 2,472,566 | 59.3% |
| 2025-08-25 | 1,018,911 | 3,009,096 | 4,028,007 | 60.6% |
| 2025-08-18 | 1,275,327 | 3,091,468 | 4,366,795 | 63.8% |
Showing 1–47 of 47 weeks
Key facts
CIK
876343
CUSIP
53566P109
13F (30d)
124 filings
123 filers
Visit website
Investor relations